The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in Lung Cancer
Background. Gefitinib resistance remains a major problem in the treatment of lung cancer. However, the underlying mechanisms involved in gefitinib resistance are largely unclear. Methods. Open-accessed data of lung cancer patients were downloaded from The Cancer Genome Atlas Program and Gene Express...
Saved in:
Main Authors: | Puwei Song (Author), Jianghui Zhou (Author), Kaiqin Wu (Author), Wenli Wang (Author), Shaorui Gu (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
by: Hongbo Zhao, et al.
Published: (2018) -
Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer
by: Honggang Wang, et al.
Published: (2017) -
In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer
by: Xiao Ling Ni, et al.
Published: (2017) -
Efficacy of gefitinib and radiotherapy combination in Indonesian patients with lung adenocarcinoma
by: Syahruddin Elisna, et al.
Published: (2018) -
Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
by: Yuhong Jiang, et al.
Published: (2021)